Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Lixoft Logo
Lixoft Growth Score
81
CB Rank
651288
Heat Score
45
Lixoft develops modeling and simulation software for advanced model-based drug development.
Acquired by
Simulations Plus Logo
Simulations Plus
Founded
obfuscation
PrivateNon-equity Assistance Antony, Ile-de-France, France11-50 lixoft.com/
Software
Software Engineering
Overview

Lixoft
Growth Score
81
Heat Score
45

Growth Score81
-5 pts
in past quarter
Heat Score 45
10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Lixoft

CB Rank
651288
Lixoft develops modeling and simulation software for advanced model-based drug development.
Acquired by
Simulations Plus Logo
Simulations Plus
Founded
obfuscation
PrivateNon-equity Assistance Antony, Ile-de-France, France11-50 lixoft.com/
Software
Software Engineering

Funding Rounds

Non-equity Assistance
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
About the Company
Lixoft develops modeling and simulation software for advanced model-based drug development. Its products offer powerful and easy solutions for population analysis in pre-clinical, clinical trials and in treatment individualization.
Phone Number +33 9 72 53 91 80
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

MonolixSuite
A suite of interoperable applications for pharmacometrics analysis, modeling, and simulation covering data visualization, non-compartmental analysis, population modeling, and simulations.
PKanalix
Graphical and interactive software for performing non-compartmental and compartmental pharmacokinetic analyses.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - Lixoft Logo
Non Equity Assistance - Lixoft
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Lixoft Logo
Non Equity Assistance - Lixoft
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Lixoft Logo
Non Equity Assistance - Lixoft
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Lixoft Logo
Non Equity Assistance - Lixoft
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Lixoft Logo
Non Equity Assistance - Lixoft
1
obfuscation
— Non-equity Assistance

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - Lixoft Logo
Non Equity Assistance - Lixoft
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Lixoft Logo
Non Equity Assistance - Lixoft
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Lixoft Logo
Non Equity Assistance - Lixoft
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Lixoft Logo
Non Equity Assistance - Lixoft
1
obfuscation
— Non-equity Assistance
obfuscation
Non Equity Assistance - Lixoft Logo
Non Equity Assistance - Lixoft
1
obfuscation
— Non-equity Assistance

Investors

M&A Details

Lixoft was acquired by Simulations Plus for
obfuscation
on
obfuscation
. This deal was done in Cash & Stock.
Transaction Name 
Lixoft acquired by Simulations Plus Logo
Lixoft acquired by Simulations Plus
Acquired by 
Simulations Plus Logo
Simulations Plus
Announced Date 
obfuscation
Price 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News

News and Press

News•Mar 9, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 5, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

313
-55.41%
 in past month

IT Spend

$1MThis year, Lixoft is projected to spend $1M on IT, according to Aberdeen.

Active Website Tech Count

18Lixoft is actively using 18 technologies for its website, according to BuiltWith. These include Common Crawl, Mobile Non Scaleable Content, and  jsDelivr.
Sub-Organizations
Frequently Asked Questions

Where is Lixoft's headquarters? Lixoft is located in Antony, Ile-de-France, France.Who invested in Lixoft? Lixoft is funded by IncubAlliance Paris-Saclay.When was the last funding round for Lixoft? Lixoft closed its last funding round on
obfuscation
from a Non-equity Assistance round.Who are Lixoft's competitors? Alternatives and possible competitors to Lixoft may include ICON, Certara, and  Almanac Labs.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(7280375 1)
|